Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donatella Treppiedi

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Frontiers in Endocrinology|August 22, 2022
Dimerization of GPCRs: Novel insight into the role of FLNA and SSAs regulating SST<sub>2</sub> and SST<sub>5</sub> homo- and hetero-dimer formationDonatella Treppiedi, Giusy Marra, Genesio Di Muro, et al.
Frontiers in Endocrinology|October 24, 2025
Potential antitumoral effects of SRPK1 inhibition through modulation of VEGF splicing in pituitary somatotroph tumoral cellsDonatella Treppiedi, Sonia Di Bari, Federica Mangili, et al.
Frontiers in Endocrinology|June 17, 2022
TMPRSS2 Expression and Activity Modulation by Sex-Related Hormones in Lung Calu-3 Cells: Impact on Gender-Specific SARS-CoV-2 InfectionDonatella Treppiedi, Giusy Marra, Genesio Di Muro, et al.
Molecular and Cellular Endocrinology|January 7, 2019
Somatostatin analogs regulate tumor corticotrophs growth by reducing ERK1/2 activityDonatella Treppiedi, Elena Giardino, Rosa Catalano, et al.
Endocrine-Related Cancer|June 19, 2026
Characterization of SF3B1 role in prolactin-secreting pituitary tumorsFederica Mangili, Anna Maria Barbieri, Genesio Di Muro, et al.
Neuroendocrinology|October 2, 2019
Cytoskeleton Protein Filamin A Is Required for Efficient Somatostatin Receptor Type 2 Internalization and Recycling through Rab5 and Rab4 Sorting Endosomes in Tumor Somatotroph CellsDonatella Treppiedi, Federica Mangili, Elena Giardino, et al.
Neuroendocrinology|June 9, 2020
Beta-Arrestin 2 Is Required for Dopamine Receptor Type 2 Inhibitory Effects on AKT Phosphorylation and Cell Proliferation in Pituitary TumorsFederica Mangili, Elena Giardino, Donatella Treppiedi, et al.
Molecular and Cellular Endocrinology|January 11, 2021
Filamin A is required for somatostatin receptor type 5 expression and pasireotide-mediated signaling in pituitary corticotroph tumor cellsDonatella Treppiedi, Genesio Di Muro, Federica Mangili, et al.
Frontiers in Endocrinology|June 20, 2022
DRD2 Agonist Cabergoline Abolished the Escape Mechanism Induced by mTOR Inhibitor Everolimus in Tumoral Pituitary CellsFederica Mangili, Emanuela Esposito, Donatella Treppiedi, et al.
Endocrine-Related Cancer|June 4, 2021
USP8 inhibitor RA-9 reduces ACTH release and cell growth in tumor corticotrophsDonatella Treppiedi, Genesio Di Muro, Giusy Marra, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Frontiers in Endocrinology|August 22, 2022
Dimerization of GPCRs: Novel insight into the role of FLNA and SSAs regulating SST<sub>2</sub> and SST<sub>5</sub> homo- and hetero-dimer formationDonatella Treppiedi, Giusy Marra, Genesio Di Muro, et al.
Frontiers in Endocrinology|October 24, 2025
Potential antitumoral effects of SRPK1 inhibition through modulation of VEGF splicing in pituitary somatotroph tumoral cellsDonatella Treppiedi, Sonia Di Bari, Federica Mangili, et al.
Frontiers in Endocrinology|June 17, 2022
TMPRSS2 Expression and Activity Modulation by Sex-Related Hormones in Lung Calu-3 Cells: Impact on Gender-Specific SARS-CoV-2 InfectionDonatella Treppiedi, Giusy Marra, Genesio Di Muro, et al.
Molecular and Cellular Endocrinology|January 7, 2019
Somatostatin analogs regulate tumor corticotrophs growth by reducing ERK1/2 activityDonatella Treppiedi, Elena Giardino, Rosa Catalano, et al.
Endocrine-Related Cancer|June 19, 2026
Characterization of SF3B1 role in prolactin-secreting pituitary tumorsFederica Mangili, Anna Maria Barbieri, Genesio Di Muro, et al.
Neuroendocrinology|October 2, 2019
Cytoskeleton Protein Filamin A Is Required for Efficient Somatostatin Receptor Type 2 Internalization and Recycling through Rab5 and Rab4 Sorting Endosomes in Tumor Somatotroph CellsDonatella Treppiedi, Federica Mangili, Elena Giardino, et al.
Neuroendocrinology|June 9, 2020
Beta-Arrestin 2 Is Required for Dopamine Receptor Type 2 Inhibitory Effects on AKT Phosphorylation and Cell Proliferation in Pituitary TumorsFederica Mangili, Elena Giardino, Donatella Treppiedi, et al.
Molecular and Cellular Endocrinology|January 11, 2021
Filamin A is required for somatostatin receptor type 5 expression and pasireotide-mediated signaling in pituitary corticotroph tumor cellsDonatella Treppiedi, Genesio Di Muro, Federica Mangili, et al.
Frontiers in Endocrinology|June 20, 2022
DRD2 Agonist Cabergoline Abolished the Escape Mechanism Induced by mTOR Inhibitor Everolimus in Tumoral Pituitary CellsFederica Mangili, Emanuela Esposito, Donatella Treppiedi, et al.
Endocrine-Related Cancer|June 4, 2021
USP8 inhibitor RA-9 reduces ACTH release and cell growth in tumor corticotrophsDonatella Treppiedi, Genesio Di Muro, Giusy Marra, et al.
Pageof 3